Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Amends Passive Stake in Alpine Income Property Trust, Maintaining 5.9% Ownership
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a continued passive beneficial ownership of 5.9% in Alpine Income Property Trust, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has disclosed an increased passive ownership stake in Arvinas, Inc., now holding 7.9% of the company's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.5% Stake in Avidity Biosciences
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.5% of Avidity Biosciences Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 3 to Schedule 13G, reporting a beneficial ownership of 8.5% of Baker Hughes Co's Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.4% Stake in BioCryst Pharmaceuticals
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.4% of BioCryst Pharmaceuticals Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 7 to Schedule 13G, reporting a 7.4% beneficial ownership stake in Cannae Holdings Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant 8% Stake in CareDx Inc.
BlackRock, Inc. has filed an amended Schedule 13G, confirming its continued beneficial ownership of 8.0% of CareDx Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Celldex Therapeutics, Disclosing 7.3% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, revealing a 7.3% beneficial ownership stake in Celldex Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 13 to its Schedule 13G, disclosing a 9.2% beneficial ownership stake in Chimera Investment Corporation as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Easterly Government Properties, Disclosing 16.6% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 7 to its Schedule 13G, reporting a 16.6% beneficial ownership stake in Easterly Government Properties Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.0% passive beneficial ownership stake in Enphase Energy Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in Evolution Petroleum Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.4% of the common stock of Fidelity National Information Services Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in 4D Molecular Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 7.8% of 4D Molecular Therapeutics Inc.'s Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.6% Passive Stake in ACM Research, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.6% beneficial ownership stake in ACM Research, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, reporting a 5.9% beneficial ownership stake in AES Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.8% passive beneficial ownership stake in Stoke Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses Continued 7.9% Stake in Kosmos Energy Ltd.
BlackRock, Inc. has filed an Amendment No. 9 to Schedule 13G, reaffirming its beneficial ownership of 7.9% of Kosmos Energy Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting a beneficial ownership of 11.8% of WillScot Holdings Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a beneficial ownership of 10.7% of Element Solutions Inc's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Stake in Ambac Financial Group
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 8.7% of Ambac Financial Group Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.9% Passive Stake in Fulgent Genetics
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 5.9% beneficial ownership in Fulgent Genetics, Inc. as a passive institutional investor.
NYSE
SCHEDULE 13G/A: BlackRock Maintains Significant Stake in Mueller Water Products, Inc. with 16.1% Ownership
BlackRock, Inc. has filed an amended Schedule 13G, reaffirming its substantial beneficial ownership of 16.1% in Mueller Water Products, Inc.'s Class A Stock.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 17.3% Stake in Ryman Hospitality Properties
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 17.3% beneficial ownership stake in Ryman Hospitality Properties, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.7% Passive Stake in Wabash National Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 8.7% of Wabash National Corp's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.4% Passive Stake in Hain Celestial Group
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.4% beneficial ownership stake in Hain Celestial Group Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 6.3% beneficial ownership stake in Green Dot Corp's Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, confirming a continued beneficial ownership of 5.1% of Nabors Industries Ltd.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, reporting a continued beneficial ownership of 15.6% of iShares Trust Common Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, reporting a 7.6% beneficial ownership stake in Mativ Holdings, Inc. as of March 31, 2025.